FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of $0.65, $0.10 better than the analyst estimate of $0.55. Revenue for the quarter came in at $52.6 million versus the consensus estimate of $58.07 million.
We achieved the first of our 2020 milestones with todays announcement of positive data in healthy... More

